February 2020

Evidence: Vital but Seldom Used Consistently by Payers

March 03, 2020

Specialty Pharmacy Times

Peer-reviewed research conducted by the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center over the past 2 years sheds some light on what’s behind discrepancies in coverage decisions from one insurer to the next.

Guselkumab Shows Efficacy as Active Psoriatic Arthritis Treatment

February 14, 2020

Specialty Pharmacy Times

Data from 2 studies evaluating guselkumab (Tremfya, Janssen) in active psoriatic arthritis were presented at the American College of Rheumatology and Association of Rheumatology Professionals 2019 Annual Meeting.